As spotlight shines on Ecuadorian judicial system, U.S. drug company, Merck, pursues a Chevron-style arbitration claim of its own

You are not logged in. If you are a subscriber, please Login to access. If you are not a subscriber, you can contact us for a rate quote at Alternatively, you can sign up to receive free email headlines here.